Cargando…
Comparison of two-drug combinations, amikacin/tigecycline/imipenem and amikacin/tigecycline/clarithromycin against Mycobacteroides abscessus subsp. abscessus using the in vitro time-kill assay
Nontuberculous mycobacteria include 198 mycobacterial species. Among these, Mycobacteroides abscessus is a rapidly growing mycobacteria that causes lung and skin infections. M. abscessus lung infections are difficult to treat due to the high levels of resistance to several classes of antibiotics. Th...
Autores principales: | Portell-Buj, Elena, Bonet-Rossinyol, Queralt, López-Gavín, Alexandre, Roman, Angely, Fernández-Pittol, Mariana, Tudó, Griselda, Gonzalez-Martin, Julian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005373/ https://www.ncbi.nlm.nih.gov/pubmed/33420382 http://dx.doi.org/10.1038/s41429-020-00392-0 |
Ejemplares similares
-
Genetic Determinants of Tigecycline Resistance in Mycobacteroides abscessus
por: Ng, Hien Fuh, et al.
Publicado: (2022) -
The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex
por: Takei, Satomi, et al.
Publicado: (2020) -
Treatment Outcome in Patients with Mycobacterium abscessus Complex Lung Disease: The Impact of Tigecycline and Amikacin
por: Yang, Jeng-How, et al.
Publicado: (2022) -
New Mycobacteroides abscessus subsp. massiliense strains with recombinant hsp65 gene laterally transferred from Mycobacteroides abscessus subsp. abscessus: Potential for misidentification of M. abscessus strains with the hsp65-based method
por: Kim, Byoung-Jun, et al.
Publicado: (2019) -
Amikacin exposure and susceptibility of macrolide-resistant Mycobacterium abscessus
por: Daniel-Wayman, Shelby, et al.
Publicado: (2019)